STAAR Surgical | STAA - Cash And Equivalent


STAAR Surgical reported $153.15M in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Abbott USD 8.52B 1.01B Dec/2025
Bausch Health Companies USD 1.31B 419M Sep/2025
Boston Scientific USD 1.96B 690M Dec/2025
Cerus USD 15.67M 321K Sep/2025
Cooper Companies USD 110.6M 14.3M Sep/2025
Hologic USD 2.17B 208.5M Dec/2025
J&J USD 19.71B 1.48B Dec/2025
Merit Medical Systems USD 446.4M 53.95M Dec/2025
Novartis USD 9.56B 2.9B Sep/2025
OraSure Technologies USD 199.28M 17.2M Dec/2025
Orthofix International USD 82.02M 19.16M Dec/2025
Rockwell Medical USD 12.48M 1.09M Jun/2025
STAAR Surgical USD 153.15M 23M Dec/2025
Utah Medical Products USD 84.27M 2.09M Sep/2025